These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 9789482)
1. Benign prostatic hyperplasia: maximizing treatment with alpha blockers. Lowenthal DT; Flannery M; Mader SL; Nelson RP Geriatrics; 1998 Oct; 53 Suppl 2():S4-28. PubMed ID: 9789482 [No Abstract] [Full Text] [Related]
2. Are the new selective alpha-blockers better than non-selective alpha-blockers for benign prostatic hyperplasia? Bèïque L; Por CP; Evans MF Can Fam Physician; 1998 Dec; 44():2659-62. PubMed ID: 9870119 [No Abstract] [Full Text] [Related]
3. Tamsulosin for benign prostatic hyperplasia. Med Lett Drugs Ther; 1997 Oct; 39(1011):96. PubMed ID: 9379999 [No Abstract] [Full Text] [Related]
4. Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms. Lowe FC Clin Ther; 2004 Nov; 26(11):1701-13. PubMed ID: 15639685 [TBL] [Abstract][Full Text] [Related]
5. Tamsulosin: the United States trials. Narayan P Geriatrics; 1998 Oct; 53 Suppl 2():S29-32. PubMed ID: 9789483 [TBL] [Abstract][Full Text] [Related]
6. [Omnic (tamsulosin) in the treatment of benign prostatic hyperplasia]. Lopatkin NA; Pytel' IuA; Trapeznikova MF; Loran OB; Mazo EB; Stepanov VN; Gres' AA; Savchenko NE; Vozianov AF; Babich VM Urologiia; 2001; (1):3-8. PubMed ID: 11233228 [No Abstract] [Full Text] [Related]
8. Terazosin for benign prostatic hyperplasia. Med Lett Drugs Ther; 1994 Feb; 36(916):15-6. PubMed ID: 7508075 [No Abstract] [Full Text] [Related]
9. A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes. Bozlu M; Ulusoy E; Cayan S; Akbay E; Görür S; Akbay E Scand J Urol Nephrol; 2004; 38(5):391-5. PubMed ID: 15764250 [TBL] [Abstract][Full Text] [Related]
10. Medical treatment of benign prostatic hyperplasia. Lancet; 1988 May; 1(8594):1083-4. PubMed ID: 2452939 [No Abstract] [Full Text] [Related]
11. Current issues and reported findings from the National Survey on Benign Prostatic Hyperplasia. Fawzy A Int J Clin Pract Suppl; 2001 Sep; (122):2-22. PubMed ID: 11695085 [No Abstract] [Full Text] [Related]
12. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination]. Hausmann R; Thalmann G; Reich O; Steif CG Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991 [No Abstract] [Full Text] [Related]
13. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia]. Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514 [No Abstract] [Full Text] [Related]
14. [Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension]. Yang MG; Zhao XK Zhonghua Nan Ke Xue; 2007 Sep; 13(9):830-4. PubMed ID: 17929564 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tamsulosin for benign prostatic hyperplasia: clinical experience in the primary care setting. Flannery MT; Ramsdell J; Ranhosky A; Davidai G; Ruoff G Curr Med Res Opin; 2006 Apr; 22(4):721-30. PubMed ID: 16684433 [TBL] [Abstract][Full Text] [Related]
16. Terazosin, finasteride, or both in benign prostatic hyperplasia. Thien T; Lenders JW N Engl J Med; 1997 Jan; 336(4):294. PubMed ID: 9005318 [No Abstract] [Full Text] [Related]
17. Cardiovascular effects of alpha-blockers for the treatment of symptomatic BPH. de Mey C Eur Urol; 1998; 34 Suppl 2():18-28; discusion 47. PubMed ID: 9732829 [No Abstract] [Full Text] [Related]
18. Alpha-adrenergic receptor antagonists in older patients with benign prostatic hyperplasia: issues and potential complications. Fine SR; Ginsberg P J Am Osteopath Assoc; 2008 Jul; 108(7):333-7. PubMed ID: 18648026 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia. Rahardjo D; Soebadi DM; Sugandi S; Birowo P; Djati W; Wahyudi I Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392 [TBL] [Abstract][Full Text] [Related]
20. Assessment of the patient with benign prostatic hyperplasia. Carlin BI; Resnick ML Compr Ther; 1996 Sep; 22(9):586-91. PubMed ID: 8902350 [No Abstract] [Full Text] [Related] [Next] [New Search]